QUOTE
Bristol Myers Squibb Co (BMY)
$
32.48
 -0.22 (-0.67%) Jan 26
|
345 Park Avenue
,
New York,
NY
10154
,
USA
+1-212-546-4000
http://www.bms.com/ |
|
|
| PRICES |
| Open |
Volume |
| 32.81 |
18.84M |
| High |
Low |
| 32.97 |
32.23 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| 55184 |
8.94M |
| 52wk High |
52wk Low |
| 35.29 |
24.97 |
|
| RATIOS |
| P/E |
EPS |
| 15.04 |
2.16 |
| BV |
P/BV |
| 9.25 |
3.51 |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| 1.32 |
4.06% |
| Shares |
Inst Owner |
| 1699.00 |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of USD)
|
| |
2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
| Income statement |
| Total Revenue |
$18,653 | $19,380 | $19,207 | $17,914 | $18,193 | $20,597 | $18,808 | $19,484 |
| Oprating Income |
$4,680 | $4,418 | $4,516 | $2,635 | $3,186 | $5,471 | $5,602 | $6,071 |
| Net Income |
$3,106 | $2,388 | $3,000 | $1,585 | $2,165 | $966 | $10,612 | $3,102 |
| Balance Sheet |
| Total Assets |
$27,448 | $30,435 | $28,138 | $25,575 | $25,926 | $29,552 | $31,008 | $31,076 |
| Total Equity |
$9,786 | $10,202 | $11,208 | $9,991 | $10,562 | $12,241 | $14,843 | $15,713 |
| Total Liabilities |
$17,662 | $20,233 | $16,930 | $15,584 | $15,364 | $17,311 | $16,165 | $15,363 |
| Cash Flow |
| Oprating |
$3,512 | $3,176 | $1,836 | $2,083 | $3,153 | $3,707 | $4,065 | $4,491 |
| Investing |
$-2,419 | $-1,622 | $1,191 | $206 | $-202 | $5,079 | $-4,380 | $-3,812 |
| Financing |
$-1,031 | $-463 | $-3,637 | $-3,351 | $-3,213 | $-2,582 | $-17 | $-3,343 |
| Net Cash Change |
$98 | $1,131 | $-630 | $-1,032 | $-217 | $6,175 | $-293 | $-2,650 |
|
Earning Call Calender
|
| 2009 | 2008 |
2007 |
2006 |
|
27 January 2009
28 April 2009
23 July 2009
22 October 2009
|
31 January 2008
24 April 2008
24 July 2008
23 October 2008
|
26 April 2007
26 July 2007
25 October 2007
|
25 January 2006
27 April 2006
27 July 2006
26 October 2006
| |
|
| Earning Call Summary |
Transcripts |
| |
|
Management
|
|
Executive |
Title |
|
James M. Cornelius |
Chairman and CEO | |
|
Jean-Marc Huet |
Senior Vice President and Chief Financial Officer |
|
John E. Celentano |
Senior Vice President, Strategy and Productivity Transformation |
|
Elliott Sigal |
Executive Vice President, Chief Scientific Officer; President of Pharmaceutical Research Institute |
|
Lamberto Andreotti |
Executive Vice President and Chief Operating Officer of Bristol-Myers Squibb |
|
Sandra Leung |
Senior Vice President, General Counsel and Corporate Secretary |
|
Anthony McBride |
Senior Vice President - Human Resources |
|
Robert T. Zito |
Senior Vice President, Corporate and Business Communications, and Chief Communications Officer |
|
Brian Daniels |
Senior Vice President, Global Development, R&D |
|
|
|
